Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Carbohydrate Research
|
January 15, 1986
Cyclic platelet-activating factor analogues derived from 2-deoxy-D-erythro-pentose
M L Phillips, R Bonjouklian
Chemistry & Biology
|
October 1, 1994
Atomic structure of the trypsin-A90720A complex: a unified approach to structure and function
A Y Lee, T A Smitka, R Bonjouklian, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1991
Hypotensive properties of the protein kinase inhibitor, staurosporine, in normotensive and spontaneously hypertensive rats
R J Secrest, P Williams, R Bonjouklian, et al.
Anti-Cancer Drug Design
|
August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity
S R Hill, R Bonjouklian, G Powis, et al.
The Journal of Antibiotics
|
April 11, 1992
A83016F, a new member of the aurodox family
T A Smitka, R Bonjouklian, T J Perun, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analogues
G Powis, A Gallegos, R T Abraham, et al.
Acta Biochimica Polonica
|
January 1, 1995
Advances with phospholipid signalling as a target for anticancer drug development
G Powis, M Berggren, A Gallegos, et al.
Journal of Medicinal Chemistry
|
December 1, 1986
Studies of the antitumor activity of (2-alkoxyalkyl)- and (2-alkoxyalkenyl)phosphocholines
R Bonjouklian, M L Phillips, K M Kuhler, et al.
Cancer Research
|
May 1, 1994
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase
G Powis, R Bonjouklian, M M Berggren, et al.
Anticancer Research
|
July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin
R M Schultz, R L Merriman, S L Andis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Carbohydrate Research
|
January 15, 1986
Cyclic platelet-activating factor analogues derived from 2-deoxy-D-erythro-pentose
M L Phillips, R Bonjouklian
Chemistry & Biology
|
October 1, 1994
Atomic structure of the trypsin-A90720A complex: a unified approach to structure and function
A Y Lee, T A Smitka, R Bonjouklian, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice
|
January 1, 1991
Hypotensive properties of the protein kinase inhibitor, staurosporine, in normotensive and spontaneously hypertensive rats
R J Secrest, P Williams, R Bonjouklian, et al.
Anti-Cancer Drug Design
|
August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activity
S R Hill, R Bonjouklian, G Powis, et al.
The Journal of Antibiotics
|
April 11, 1992
A83016F, a new member of the aurodox family
T A Smitka, R Bonjouklian, T J Perun, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analogues
G Powis, A Gallegos, R T Abraham, et al.
Acta Biochimica Polonica
|
January 1, 1995
Advances with phospholipid signalling as a target for anticancer drug development
G Powis, M Berggren, A Gallegos, et al.
Journal of Medicinal Chemistry
|
December 1, 1986
Studies of the antitumor activity of (2-alkoxyalkyl)- and (2-alkoxyalkenyl)phosphocholines
R Bonjouklian, M L Phillips, K M Kuhler, et al.
Cancer Research
|
May 1, 1994
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase
G Powis, R Bonjouklian, M M Berggren, et al.
Anticancer Research
|
July 1, 1995
In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin
R M Schultz, R L Merriman, S L Andis, et al.
Page
of 2